EMD-22852

Single-particle
9.9 Å
EMD-22852
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 28/04/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22852
Download
3D volume (map.gz) Experimental metadata (xml)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-237 and EBOV-515

EMD-22852

Single-particle
9.9 Å
EMD-22852
3D View Gallery
Deposition: 13/10/2020
Map released: 28/04/2021
Last modified: 28/04/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus, Homo sapiens
Sample: Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-237 and EBOV-515

Deposition Authors: Murin CD, Ward AB
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Murin CD, Gilchuk P, Ilinykh PA, Huang K , Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, Crowe Jr JE, Ward AB
(2021) Cell Rep , 35 , 108984 - 108984
PUBMED: 33852862
DOI: doi:10.1016/j.celrep.2021.108984
ISSN: 2211-1247